SynOx Therapeutics
Description: SynOx Therapeutics develops emactuzumab, a monoclonal antibody for treating tenosynovial giant cell tumors (TGCT) and macrophage-driven diseases.
Country: Ireland
Based in: Dublin
Founded: 2020
Funding Stage: Series A/B
Tags: ['Biotechnology', 'Medical', 'Clinical Dta']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
